These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Tenascin-X as a causal gene for classical-like Ehlers-Danlos syndrome. Okuda-Ashitaka E; Matsumoto KI Front Genet; 2023; 14():1107787. PubMed ID: 37007968 [TBL] [Abstract][Full Text] [Related]
5. Measurement of serum tenascin-X in patients with congenital adrenal hyperplasia at risk for Ehlers-Danlos contiguous gene deletion syndrome CAH-X. Kolli V; Kim H; Rao H; Lao Q; Gaynor A; Milner JD; Merke DP BMC Res Notes; 2019 Oct; 12(1):711. PubMed ID: 31666125 [TBL] [Abstract][Full Text] [Related]
7. Invasion of melanoma in double knockout mice lacking tenascin-X and tenascin-C. Matsumoto K; Takahashi K; Yoshiki A; Kusakabe M; Ariga H Jpn J Cancer Res; 2002 Sep; 93(9):968-75. PubMed ID: 12359049 [TBL] [Abstract][Full Text] [Related]
8. Wound healing-related properties detected in an experimental model with a collagen gel contraction assay are affected in the absence of tenascin-X. Hashimoto K; Kajitani N; Miyamoto Y; Matsumoto KI Exp Cell Res; 2018 Feb; 363(1):102-113. PubMed ID: 29291401 [TBL] [Abstract][Full Text] [Related]
9. Multiple Roles of Tenascins in Homeostasis and Pathophysiology of Aorta. Imanaka-Yoshida K; Matsumoto KI Ann Vasc Dis; 2018 Jun; 11(2):169-180. PubMed ID: 30116408 [TBL] [Abstract][Full Text] [Related]
11. The Roles of Tenascins in Cardiovascular, Inflammatory, and Heritable Connective Tissue Diseases. Matsumoto KI; Aoki H Front Immunol; 2020; 11():609752. PubMed ID: 33335533 [TBL] [Abstract][Full Text] [Related]
12. The extracellular matrix glycoprotein tenascin-X regulates peripheral sensory and motor neurones. Aktar R; Peiris M; Fikree A; Cibert-Goton V; Walmsley M; Tough IR; Watanabe P; Araujo EJA; Mohammed SD; Delalande JM; Bulmer DC; Scott SM; Cox HM; Voermans NC; Aziz Q; Blackshaw LA J Physiol; 2018 Sep; 596(17):4237-4251. PubMed ID: 29917237 [TBL] [Abstract][Full Text] [Related]
13. TNX deficiency results in bone loss due to an increase in multinucleated osteoclasts. Kajitani N; Yamada T; Kawakami K; Matsumoto KI Biochem Biophys Res Commun; 2019 May; 512(4):659-664. PubMed ID: 30922562 [TBL] [Abstract][Full Text] [Related]
14. Clinical and Molecular Characterization of Classical-Like Ehlers-Danlos Syndrome Due to a Novel Rymen D; Ritelli M; Zoppi N; Cinquina V; Giunta C; Rohrbach M; Colombi M Genes (Basel); 2019 Oct; 10(11):. PubMed ID: 31731524 [TBL] [Abstract][Full Text] [Related]
15. Induction of matrix metalloproteinase-2 by tenascin-X deficiency is mediated through the c-Jun N-terminal kinase and protein tyrosine kinase phosphorylation pathway. Matsumoto K; Minamitani T; Orba Y; Sato M; Sawa H; Ariga H Exp Cell Res; 2004 Jul; 297(2):404-14. PubMed ID: 15212943 [TBL] [Abstract][Full Text] [Related]
16. Mild muscular features in tenascin-X knockout mice, a model of Ehlers-danlos syndrome. Voermans NC; Verrijp K; Eshuis L; Balemans MC; Egging D; Sterrenburg E; van Rooij IA; van der Laak JA; Schalkwijk J; van der Maarel SM; Lammens M; van Engelen BG Connect Tissue Res; 2011 Oct; 52(5):422-32. PubMed ID: 21405982 [TBL] [Abstract][Full Text] [Related]
17. The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse. Imanaka-Yoshida K; Matsumoto K; Hara M; Sakakura T; Yoshida T Differentiation; 2003 Jun; 71(4-5):291-8. PubMed ID: 12823230 [TBL] [Abstract][Full Text] [Related]
18. Recognizing the tenascin-X deficient type of Ehlers-Danlos syndrome: a cross-sectional study in 17 patients. Demirdas S; Dulfer E; Robert L; Kempers M; van Beek D; Micha D; van Engelen BG; Hamel B; Schalkwijk J; Loeys B; Maugeri A; Voermans NC Clin Genet; 2017 Mar; 91(3):411-425. PubMed ID: 27582382 [TBL] [Abstract][Full Text] [Related]